Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance »
04/08/14

A Complex Molecular Network »
04/08/14

Post-transplantation cyclophosphamide (PT-CY) after myeloablative conditioning regimen (MAC) in Unmanipulated Haploidentical Bone Marrow Transplantation (hBMT) Is Highly Effective As GVHD Prophylaxis and Disease Free Survival In Pediatric and Adult Patients With High Risk Leukemia »
04/08/14

Aberrant Splicing In Patients With AML Is Associated With Over- Expression Of Specific Splicing Factors »
04/08/14

Mutations In XPO1, POT1, BIRC3 and FBXW7 »
04/08/14

Chemo-Immunotherapy Combination Of Idelalisib With Bendamustine/Rituximab Or Chlorambucil/Rituximab »
04/08/14

Chimeric Antigen Receptor Modified T Cells »
04/08/14

Low-Dose Lenalidomide Improves CAR-Based Immunotherapy »
04/08/14

Effect Of MYD88 Mutation »
04/08/14

Concomitant, T-Independent TLR9-Mediated and BCR-Mediated Activation Provides Signals For Optimal Telomerase Induction In Chronic Lymphocytic Leukemia Cells Regardless Of IGHV Mutation Status »
04/08/14